Nivolumab vs Spironolactone

## Nivolumab vs Spironolactone: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Spironolactone**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Spironolactone**: Mineralocorticoid receptor antagonist.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Spironolactone — 1.4 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Spironolactone — C24H32O4S.

**Molecular Weight**: Nivolumab — N/A; Spironolactone — 416.5740 g/mol.

**Type**: Nivolumab — Antibody; Spironolactone — Small molecule.